Occudo Quantitative Strategies LP Geron Corp Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.75 - $3.44 $18,187 - $35,751	10,393 New	10,393 $34,000
Q3 2023 Nov 14, 2023	BUY	$2.11 - $3.28 $487,536 - $757,876	231,060 New	231,060 $489,000
Q1 2023 May 15, 2023	SELL	$2.14 - $3.4 $144,830 - $230,105	-67,678 Reduced 31.22%	149,069 $323,000
Q4 2022 Feb 14, 2023	BUY	$2.03 - $2.42 $271,524 - $323,689	133,756 Added 161.17%	216,747 $524,000
Q3 2022 Nov 14, 2022	BUY	$1.67 - $2.94 $138,594 - $243,993	82,991 New	82,991 $194,000

274

491M

1.87M

690K

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.32B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.